Când viaţa câştigă

Emoţie… emoţie… pe ecranul ecografului se vede un punct. Un punct care bate. Încă o mişcare şi…da! Este inima Anastasiei, o nouă viaţă ce porneşte la drum. O viaţă ce va schimba vieţi.

Anastasia s-a născut în anul 2011 în Bucureşti. A adus bucurie în familie şi multe lacrimi de fericire. Câţiva ani mai târziu Anastasia a adus şi lacrimi de neputinţă. Fără să depindă ceva de ea, fără că părinţii să poată face ceva înainte, Anastasia a aflat că suferă de tetrapareză cerebrală infantilă formă spastică distonică bilaterală, o boală cauzată de lipsa oxigenării creierului pentru un interval de timp, la naştere.

Toamna lui 2015

În casa Anastasiei este acum linişte, micuţa doarme iar părinţii ei sunt în bucătărie. Telefonul le aduce o veste neaşteptată şi în acelaşi timp greu de înţeles. Anastasia ar putea face parte din echipa celor care creează medicină viitorului. Anastasia poate fi un deschizător de drumuri, un copil care poate scrie istorie. Celulele stem recoltate de mama la naşterea ei, ar putea să fie puse la treabă şi să ajute în tratamentul de care suferă acum micuţa.

Ai putea să refuzi o asemenea ştire? Ai putea oare să spui că nu vrei să încerci? Mama Anastasiei a spus DA!

…şi aventura începe

În toamna anului 2015, Anastasia merge pentru prima dată în Polonia, la spitalul Spitalul Universitar de Copii din Cracovia, ajutată de către Biogenis, banca de celule stem unde are stocate acum şi celulele stem. Fetiţa primeşte prima infuzie cu celule stem şi pleacă acasă chiar a doua zi după intervenţie.

După doar două săptămâni, părinţii Anastasiei observă şi primele rezultate pozitive. Pentru prima dată, Anastasia spune mama, pentru că mai apoi fetiţa să poată mânca, să poată înghiţi, să-şi îmbunătăţească motricitatea. Mai are un drum lung de parcus însă speranţa a prins aripi şi merge mai departe. Anul acesta Anastasia a fost din nou în Polonia şi a mai făcut o intervenţie. Cu siguranţă vor urmă şi altele. Cu toţii ne dorim să vedem rezultatele cât mai repede, încurajaţi fiind şi de sutele de oameni care fac un tratament cu celule stem chiar acum, în grupul de bănci de celule stem din care face parte şi Biogenis, banca ce a stocat pentru prima dată celulele stem ale Anastasiei. 739 de pacienţi sunt trataţi acum în acest grup, prin terapii standard şi experimentale, încercându-se o rezolvare pentru boli precum epilepsie, Alzheimer, autism, scleroză laterală, paralizie cerebrală, scleroză multiplă, encefalopatie, orbire…

Cand viata castiga, nimic nu te mai poate opri. Cand viata castiga, te bucuri ca ai facut ce trebuia, ii inveti si pe altii si aduci bucurie la randul tau.

Poţi vedea poveştile Biogenis pe www.biogenis.ro/candviatacastiga

Biogenis, mai mult decât o bancă de celule stem.

 

Lista cu utilizări în grupul din care face parte Biogenis

No.Cell sourceIndicationArea of medicineYearType of therapyCountryAge
1cord bloodCD40 ligand deficiencyhematology2017standard therapyTurkey9,6
2cord bloodtalassemia majorhematology2017standard therapyTurkey4,0
3cord bloodtalassemia majorhematology2017standard therapyTurkey4,1
4cord bloodcerebral palsyneurology2017experimental therapyPoland2,2
5cord bloodcerebral palsyneurology2017experimental therapyPoland5,4
6cord bloodcerebral palsyneurology2017experimental therapyPoland10,3
7cord bloodautismneurology2017experimental therapyPoland4,11
8cord bloodacute myeloid leukemiahematology2016standard therapyJordan6
9cord bloodautismneurology2016experimental therapyPoland6
10cord bloodacute lymphoblastic leukemiahematology2016standard therapyHungary7
11cord bloodacute lymphoblastic leukemiahematology2015standard therapyPoland4
12cord bloodacute lymphoblastic leukemiahematology2014standard therapyTurkey7
13cord bloodaplastic anaemiahematology2013standard therapyPoland3
14cord bloodacute myeloid leukemiahematology2013standard therapyPoland3
15cord bloodbeta-talassemia; agranulocytosishematology2013standard therapyTurkey8
16cord bloodX - linked lymphoproliferative syndromehematology2013standard therapyPoland10/12
17cord bloodsevere aplastic anaemiahematology2012standard therapyHungary3
18cord bloodanaemia, talassemia majorhematology2012standard therapyTurkey6
19cord bloodtalassemia major, acute lymphoblastic leukemiahematology2012standard therapyTurkey3,5
20cord bloodT-acute lymphoblastic leukemiahematology2012standard therapyTurkey5
21cord bloodFanconi anemiahematology2011standard therapyPoland12
22cord bloodacute myeloid leukemiahematology2011standard therapyHungary2
23cord bloodacute lymphoblastic leukemiahematology2011standard therapyPoland5
24cord bloodhistiocytosishematology2011standard therapyPoland2,5
25cord bloodchronic granulomatous diseasehematology2011standard therapyPoland7,5
26cord bloodpre -B acute lymphoblastic leukemiahematology2010standard therapyHungary1,5
27cord bloodmyelodysplastic syndromehematology2009standard therapyPoland5
28cord bloodacute lymphoblastic leukemiahematology2008standard therapyPoland5
29cord bloodcerebral ischemianeurology2008experimental therapyPoland1,5
30cord bloodneuroblastomahematology2007standard therapyPoland8
31cord tissue (Wharton's jelly)cerebral palsyneurology2017experimental therapyPoland2,10
32cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland67,11
33cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland37,9
34cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland71,7
35cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPolandno data
36cord tissue (Wharton's jelly)autismneurology2017experimental therapyPoland7,11
37cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland47,6
38cord tissue (Wharton's jelly)spinocerebellar ataxianeurology2017experimental therapyPoland44,1
39cord tissue (Wharton's jelly)spinal cord injuryorthopedics2017experimental therapyPoland34,11
40cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2017experimental therapyPoland58,10
41cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2017experimental therapyPoland49,0
42cord tissue (Wharton's jelly)Stargardt's diseaseophthalmology2017experimental therapyPoland37,4
43cord tissue (Wharton's jelly)muscular dystrophyneurology2017experimental therapyPoland37,7
44cord tissue (Wharton's jelly)muscular dystrophyneurology2017experimental therapyPoland26,11
45cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland56,7
46cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland48,11
47cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland46,3
48cord tissue (Wharton's jelly)cartilage damageorthopedics2017experimental therapyPoland61,5
49cord tissue (Wharton's jelly)spinal cord injuryorthopedics2017experimental therapyPoland34,1
50cord tissue (Wharton's jelly)sclerosis multiplexneurology2017experimental therapyPoland52,9
51cord tissue (Wharton's jelly)atrophy of the optic nervesophthalmology2017experimental therapyPoland23,9
52cord tissue (Wharton's jelly)Stargardt's diseaseophthalmology2017experimental therapyPoland31,6
53cord tissue (Wharton's jelly)age-related macular degenerationophthalmology2017experimental therapyPoland33,4
54cord tissue (Wharton's jelly)tetraparesis spasticaneurology2017experimental therapyPoland29,4
55cord tissue (Wharton's jelly)spinal cord injuryorthopedics2017experimental therapyPoland24,9
56cord tissue (Wharton's jelly)spinal muscular atrophyneurology2017experimental therapyPoland10,6
57cord tissue (Wharton's jelly)Stargardt's diseaseophthalmology2017experimental therapyPoland30,0
58cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2017experimental therapyPoland56,8
59cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2017experimental therapyPoland65,2
60cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland45,9
61cord tissue (Wharton's jelly)dystrophia progressiva pseudohypertrophica /DMDneurology2017experimental therapyPoland28,6
62cord tissue (Wharton's jelly)limb-girdle muscular dystrophyneurology2017experimental therapyPoland44,2
63cord tissue (Wharton's jelly)spinal muscular atrophyneurology2017experimental therapyPoland41,4
64cord tissue (Wharton's jelly)limb-girdle muscular dystrophyneurology2017experimental therapyPoland25,8
65cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland75,9
66cord tissue (Wharton's jelly)Stargardt's diseaseophthalmology2017experimental therapyPoland23,7
67cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2017experimental therapyPoland43,4
68cord tissue (Wharton's jelly)optic atrophyophthalmology2017experimental therapyPoland39,0
69cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland51,3
70cord tissue (Wharton's jelly)spinal cord injuryorthopedics2017experimental therapyPoland39,0
71cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2017experimental therapyPoland42,11
72cord tissue (Wharton's jelly)optic atrophyophthalmology2017experimental therapyPoland30,9
73cord tissue (Wharton's jelly)spinal muscular atrophyneurology2017experimental therapyPoland12,11
74cord tissue (Wharton's jelly)spinal muscular atrophyneurology2017experimental therapyPoland8,5
75cord tissue (Wharton's jelly)gonarthrosisorthopedics2017experimental therapyPoland58,9
76cord tissue (Wharton's jelly)cri du chat syndromeneurology2017experimental therapyPoland8,6
77cord tissue (Wharton's jelly)cerebral palsyneurology2017experimental therapyPoland18,7
78cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland59,8
79cord tissue (Wharton's jelly)muscular dystrophyneurology2017experimental therapyPoland22,1
80cord tissue (Wharton's jelly)dystrophia progressiva pseudohypertrophica /DMDneurology2017experimental therapyPoland28,11
81cord tissue (Wharton's jelly)epilepsianeurology2017experimental therapyPoland3,1
82cord tissue (Wharton's jelly)cranium bifidumneurology2017experimental therapyPoland5,2
83cord tissue (Wharton's jelly)transverse myelitisneurology2017experimental therapyPoland8,3
84cord tissue (Wharton's jelly)syringomielianeurology2017experimental therapyPoland42,6
85cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland64,9
86cord tissue (Wharton's jelly)sclerosis multiplexneurology2017experimental therapyPoland47,2
87cord tissue (Wharton's jelly)limb-girdle muscular dystrophyneurology2017experimental therapyPoland38,5
88cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland56,7
89cord tissue (Wharton's jelly)autismneurology2017experimental therapyPoland13,4
90cord tissue (Wharton's jelly)encephalopathyneurology2017experimental therapyPoland21,10
91cord tissue (Wharton's jelly)encephalopathyneurology2017experimental therapyPoland5,0
92cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2017experimental therapyPoland41,0
93cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2017experimental therapyPoland52,1
94cord tissue (Wharton's jelly)cerebral palsy; neonatal cerebral leukomalacianeurology2017experimental therapyPoland1,9
95cord tissue (Wharton's jelly)autismneurology2017experimental therapyPoland11,11
96cord tissue (Wharton's jelly)limb-girdle muscular dystrophyneurology2017experimental therapyPoland26,10
97cord tissue (Wharton's jelly)autismneurology2017experimental therapyPoland9,1
98cord tissue (Wharton's jelly)cerebellar syndromeneurology2017experimental therapyPoland11,5
99cord tissue (Wharton's jelly)congenital fiber-type disproportion myopathyneurology2017experimental therapyPoland1,10
100cord tissue (Wharton's jelly)chronic myeloid leukemiahematology2017experimental therapyPoland5,11
101cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2017experimental therapyPoland61,5
102cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland40,11
103cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2017experimental therapyPoland48,1
104cord tissue (Wharton's jelly)spina bifidaneurology2017experimental therapyPoland1,11
105cord tissue (Wharton's jelly)muscular dystrophyneurology2017experimental therapyPoland37,11
106cord tissue (Wharton's jelly)arthrogryposis multiplex congenitaneurology2017experimental therapyPoland1,7
107cord tissue (Wharton's jelly)encephalopathy; cerebral palsyneurology2017experimental therapyPoland4,4
108cord tissue (Wharton's jelly)cerebral palsy; epilepsyneurology2017experimental therapyPoland5,8
109cord tissue (Wharton's jelly)spinal cord injuryorthopedics2017experimental therapyPoland6,4
110cord tissue (Wharton's jelly)cerebral palsyneurology2017experimental therapyPoland15,4
111cord tissue (Wharton's jelly)traumatic brain injuryneurology2017experimental therapyPoland9,4
112cord tissue (Wharton's jelly)no bone adhesionorthopedics2017experimental therapyPoland14,1
113cord tissue (Wharton's jelly)no bone adhesionorthopedics2017experimental therapyPoland17,11
114cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland69,10
115cord tissue (Wharton's jelly)spinal muscular atrophyneurology2017experimental therapyPoland24,9
116cord tissue (Wharton's jelly)optic atrophyophthalmology2017experimental therapyPoland37,7
117cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2017experimental therapyPoland31,1
118cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2017experimental therapyPoland52,11
119cord tissue (Wharton's jelly)Stargardt's diseaseophthalmology2017experimental therapyPoland27,11
120cord tissue (Wharton's jelly)Stargardt's diseaseophthalmology2017experimental therapyPoland45,4
121cord tissue (Wharton's jelly)muscular dystrophyneurology2017experimental therapyPoland34,10
122cord tissue (Wharton's jelly)muscular dystrophyneurology2017experimental therapyPoland31,6
123cord tissue (Wharton's jelly)hydrocephalus; neonatal cerebral leukomalacianeurology2017experimental therapyPoland2,3
124cord tissue (Wharton's jelly)autismneurology2017experimental therapyPoland6,3
125cord tissue (Wharton's jelly)autismneurology2017experimental therapyPoland7,11
126cord tissue (Wharton's jelly)delayed psychomotor developmentneurology2017experimental therapyPoland3,5
127cord tissue (Wharton's jelly)delayed psychomotor developmentneurology2017experimental therapyPoland6,3
128cord tissue (Wharton's jelly)syndrom IFAPhematology2017experimental therapyPoland3,5
129cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland52,0
130cord tissue (Wharton's jelly)acute graft versus host diseasehematology2017experimental therapyPoland13,0
131cord tissue (Wharton's jelly)acute graft versus host diseasehematology2017experimental therapyPoland11,10
132cord tissue (Wharton's jelly)optic atrophyophthalmology2017experimental therapyPoland66,11
133cord tissue (Wharton's jelly)ischemia within the optic nerveophthalmology2017experimental therapyPoland37,11
134cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland35,1
135cord tissue (Wharton's jelly)cerebral palsyneurology2017experimental therapyPoland4,11
136cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland77,2
137cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2017experimental therapyPoland36,11
138cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2017experimental therapyPoland63,11
139cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland35,6
140cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2017experimental therapyPoland31,9
141cord tissue (Wharton's jelly)cerebral palsyneurology2017experimental therapyPoland31,9
142cord tissue (Wharton's jelly)autismneurology2017experimental therapyPoland10,2
143cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland33,5
144cord tissue (Wharton's jelly)cerebral palsyneurology2017experimental therapyPoland5,7
145cord tissue (Wharton's jelly)cerebral palsyneurology2017experimental therapyPoland12,5
146cord tissue (Wharton's jelly)cerebral palsyneurology2017experimental therapyPoland5,9
147cord tissue (Wharton's jelly)cerebral palsyneurology2017experimental therapyPoland3,3
148cord tissue (Wharton's jelly)delayed psychomotor developmentneurology2017experimental therapyPoland5,0
149cord tissue (Wharton's jelly)hypoxia-ischemic encephalopathyneurology2017experimental therapyPoland1,9
150cord tissue (Wharton's jelly)Krabbe diseaseneurology2017experimental therapyPoland6,3
151cord tissue (Wharton's jelly)spinocerebellar ataxianeurology2017experimental therapyPoland24,6
152cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland51,6
153cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2017experimental therapyPoland45,5
154cord tissue (Wharton's jelly)optic atrophyophthalmology2017experimental therapyPoland31,5
155cord tissue (Wharton's jelly)Stargardt's diseaseophthalmology2017experimental therapyPoland48,10
156cord tissue (Wharton's jelly)muscular dystrophyneurology2017experimental therapyPoland62,5
157cord tissue (Wharton's jelly)cerebellar syndromeneurology2017experimental therapyPoland60,5
158cord tissue (Wharton's jelly)cerebral palsyneurology2017experimental therapyPoland6,1
159cord tissue (Wharton's jelly)autismneurology2017experimental therapyPoland4,8
160cord tissue (Wharton's jelly)spina bifidaneurology2017experimental therapyPoland6,4
161cord tissue (Wharton's jelly)spina bifidaneurology2017experimental therapyPoland6,3
162cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland46,0
163cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2017experimental therapyPoland49,1
164cord tissue (Wharton's jelly)condition after encephalitisneurology2017experimental therapyPoland19,7
165cord tissue (Wharton's jelly)muscular dystrophyneurology2017experimental therapyPoland35,4
166cord tissue (Wharton's jelly)spina bifidaneurology2017experimental therapyPoland1,10
167cord tissue (Wharton's jelly)autismneurology2017experimental therapyPoland6,8
168cord tissue (Wharton's jelly)encephalopathy; cerebral palsyneurology2017experimental therapyPoland1,5
169cord tissue (Wharton's jelly)autismneurology2017experimental therapyPoland7,0
170cord tissue (Wharton's jelly)cerebral palsyneurology2017experimental therapyPoland13,6
171cord tissue (Wharton's jelly)muscular dystrophyneurology2017experimental therapyPoland6,7
172cord tissue (Wharton's jelly)facio-scapulo-humeral muscular dystrophyneurology2017experimental therapyPoland32,3
173cord tissue (Wharton's jelly)sclerosis multiplexneurology2017experimental therapyPoland46,9
174cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland54,10
175cord tissue (Wharton's jelly)dystrophia myotonicaneurology2017experimental therapyPoland41,11
176cord tissue (Wharton's jelly)global developmental delayneurology2017experimental therapyPoland4,7
177cord tissue (Wharton's jelly)optic neuropathyophthalmology2017experimental therapyPoland56,4
178cord tissue (Wharton's jelly)spina bifidaneurology2017experimental therapyPoland4,1
179cord tissue (Wharton's jelly)spina bifidaneurology2017experimental therapyPoland3,6
180cord tissue (Wharton's jelly)facio-scapulo-humeral muscular dystrophyneurology2017experimental therapyPoland33,4
181cord tissue (Wharton's jelly)muscular dystrophyneurology2017experimental therapyPoland42,1
182cord tissue (Wharton's jelly)acute graft versus host diseasehematology2017experimental therapyPoland2,4
183cord tissue (Wharton's jelly)optic neuropathyophthalmology2017experimental therapyPoland30,11
184cord tissue (Wharton's jelly)optic atrophyophthalmology2017experimental therapyPoland39,7
185cord tissue (Wharton's jelly)autismneurology2017experimental therapyPoland4,8
186cord tissue (Wharton's jelly)cerebral palsyneurology2017experimental therapyPoland8,2
187cord tissue (Wharton's jelly)spina bifidaneurology2017experimental therapyPoland3,4
188cord tissue (Wharton's jelly)spina bifidaneurology2017experimental therapyPoland2,11
189cord tissue (Wharton's jelly)delayed psychomotor developmentneurology2017experimental therapyPoland7,9
190cord tissue (Wharton's jelly)arthrogryposis multiplex congenitaneurology2017experimental therapyPoland3,5
191cord tissue (Wharton's jelly)dystrophia myotonicaneurology2017experimental therapyPoland3,2
192cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland63,2
193cord tissue (Wharton's jelly)optic atrophyophthalmology2017experimental therapyPoland76,10
194cord tissue (Wharton's jelly)dystrophia progressiva pseudohypertrophica /BMDneurology2017experimental therapyPoland23,9
195cord tissue (Wharton's jelly)cerebral palsyneurology2017experimental therapyPoland3,7
196cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland43,8
197cord tissue (Wharton's jelly)optic neuropathyophthalmology2017experimental therapyPoland74,5
198cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland64,7
199cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland51,6
200cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland70,11
201cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland65,1
202cord tissue (Wharton's jelly)encephalopathyneurology2017experimental therapyPoland5,5
203cord tissue (Wharton's jelly)cerebral palsyneurology2017experimental therapyPoland8,4
204cord tissue (Wharton's jelly)cerebral palsyneurology2017experimental therapyPoland15,1
205cord tissue (Wharton's jelly)spina bifidaneurology2017experimental therapyPoland5,8
206cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2017experimental therapyPoland51,3
207cord tissue (Wharton's jelly)muscular dystrophyneurology2017experimental therapyPoland12,10
208cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2017experimental therapyPoland26,9
209cord tissue (Wharton's jelly)cerebral palsyneurology2017experimental therapyPoland18,4
210cord tissue (Wharton's jelly)autismneurology2017experimental therapyPoland10,8
211cord tissue (Wharton's jelly)autismneurology2017experimental therapyPoland13,1
212cord tissue (Wharton's jelly)cerebral palsyneurology2017experimental therapyPoland7,9
213cord tissue (Wharton's jelly)cerebral palsyneurology2017experimental therapyPoland5,5
214cord tissue (Wharton's jelly)cerebral palsyneurology2017experimental therapyPoland3,7
215cord tissue (Wharton's jelly)cerebral palsyneurology2017experimental therapyPoland3,5
216cord tissue (Wharton's jelly)cerebral palsyneurology2017experimental therapyPoland5,1
217cord tissue (Wharton's jelly)cerebral palsyneurology2017experimental therapyPoland3,4
218cord tissue (Wharton's jelly)Devic’s diseaseneurology2017experimental therapyPoland45,2
219bone marrowacute lymphoblastic leukemiahematology2017standard therapyPoland6
220bone marrowacute myelogenous leukemiahematology2017standard therapyGermany76
221bone marrowacute myelogenous leukemiahematology2017standard therapyTurkey22
222bone marrowchronic granulomatous diseasehematology2017standard therapyPoland2
223bone marrowacute myelogenous leukemiahematology2017standard therapyGermany65
224bone marrowmyelodysplastic syndromehematology2017standard therapyItaly60
225bone marrowmyelodysplastic syndromehematology2017standard therapyUSA61
226bone marrowacute lymphoblastic leukemiahematology2017standard therapyRussia30
227bone marrowchronic granulomatous diseasehematology2017standard therapyPoland4
228bone marrowleukemiahematology2017standard therapyUSA40
229bone marrowacute lymphoblastic leukemiahematology2017standard therapyUnited Kingdom10
230bone marrowacute lymphoblastic leukemiahematology2017standard therapyHungary14
231bone marrowsevere combined immunodeficiencyhematology2017standard therapyTurkey6
232bone marrowacute myelogenous leukemiahematology2017standard therapyItaly55
233bone marrowacute myelogenous leukemiahematology2017standard therapyUSA67
234bone marrowacute lymphoblastic leukemiahematology2017standard therapyPoland16
235bone marrow severe combined immunodeficiencyhematology2017standard therapyLithuania1
236bone marrowacute myelogenous leukemiahematology2017standard therapyItaly13
237bone marrowacute lymphoblastic leukemiahematology2017standard therapyItaly38
238bone marrowacute lymphoblastic leukemiahematology2017standard therapyUnited Kingdom9
239bone marrow severe combined immunodeficiencyhematology2017standard therapyCanada1
240bone marrowacute myelogenous leukemiahematology2017standard therapyRussia59
241bone marrowacute lymphoblastic leukemiahematology2017standard therapyUSA21
242bone marrow severe combined immunodeficiencyhematology2017standard therapyTurkey2
243bone marrowhyper IgM syndromehematology2017standard therapyFinland2
244bone marrowacute lymphoblastic leukemiahematology2017standard therapyAustria3
245bone marrowacute myelogenous leukemiahematology2017standard therapyRussia1
246bone marrowacute myelogenous leukemiahematology2017standard therapyItaly59
247bone marrowacute myelogenous leukemiahematology2017standard therapyUSA57
248bone marrowpure red cell aplasiahematology2017standard therapyUSA5
249bone marrowthalassemia majorhematology2017standard therapyTurkey11
250bone marrowacute myelogenous leukemiahematology2017standard therapyItaly10
251bone marrowacute myelogenous leukemiahematology2017standard therapyCzech Republic68
252bone marrowacute myelogenous leukemiahematology2017standard therapyUSA60
253bone marrowFanconi anaemiahematology2017standard therapyRussia10
254bone marrowacute myelogenous leukemiahematology2017standard therapyUSA10
255bone marrowacute myelogenous leukemiahematology2017standard therapyUSA17
256bone marrowacute myelogenous leukemiahematology2017standard therapyUSA51
257bone marrowjuvenile myelomonocytic leukemiahematology2017standard therapyFinland1
258bone marrowacute megakaryocytic leukemiahematology2017standard therapySpain2
259bone marrowchronic myeloid leukemiahematology2017standard therapyUSA51
260bone marrowacute myelogenous leukemiahematology2017standard therapyItaly56
261bone marrowacute myelogenous leukemiahematology2017standard therapyRussia54
262bone marrowacute myelogenous leukemiahematology2017standard therapyFrance24
263bone marrow severe combined immunodeficiencyhematology2017standard therapyPoland1
264bone marrowacute lymphoblastic leukemiahematology2017standard therapyUnited Kingdom8
265cord tissue (Wharton's jelly)cerebral palsyneurology2016experimental therapyPoland10,11
266cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland44,5
267cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland60,8
268cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland32,2
269cord tissue (Wharton's jelly)spinocerebellar ataxianeurology2016experimental therapyPoland64
270cord tissue (Wharton's jelly)spinocerebellar ataxianeurology2016experimental therapyPoland62,5
271cord tissue (Wharton's jelly)autismneurology2016experimental therapyPoland18,4
272cord tissue (Wharton's jelly)dystrophia progressiva pseudohypertrophica /DMDneurology2016experimental therapyPoland48,8
273cord tissue (Wharton's jelly)cerebral palsyneurology2016experimental therapyPoland10,3
274cord tissue (Wharton's jelly)facio-scapulo-humeral muscular dystrophyneurology2016experimental therapyPoland35,3
275cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland53,7
276cord tissue (Wharton's jelly)cerebral palsyneurology2016experimental therapyPoland12,2
277cord tissue (Wharton's jelly)delayed psychomotor developmentneurology2016experimental therapyPoland3,10
278cord tissue (Wharton's jelly)acute graft versus host diseasehematology2016experimental therapyPoland14
279cord tissue (Wharton's jelly)acute graft versus host diseasehematology2016experimental therapyPoland6
280cord tissue (Wharton's jelly)gonarthrosisorthopedics2016experimental therapyPoland65,8
281cord tissue (Wharton's jelly)leukodystrophyneurology2016experimental therapyPoland2,9
282cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland59,4
283cord tissue (Wharton's jelly)autismneurology2016experimental therapyPoland6
284cord tissue (Wharton's jelly)cerebral palsyneurology2016experimental therapyPoland2,11
285cord tissue (Wharton's jelly)autismneurology2016experimental therapyPoland12,11
286cord tissue (Wharton's jelly)cerebral palsyneurology2016experimental therapyPoland9,7
287cord tissue (Wharton's jelly)atrophy of the optic nervesophthalmology2016experimental therapyPoland20,3
288cord tissue (Wharton's jelly)Stargardt's diseaseophthalmology2016experimental therapyPoland53
289cord tissue (Wharton's jelly)spinal cord injuryorthopedics2016experimental therapyPoland33,5
290cord tissue (Wharton's jelly)spinal cord injuryorthopedics2016experimental therapyPoland22,2
291cord tissue (Wharton's jelly)cerebral palsyneurology2016experimental therapyPoland10,3
292cord tissue (Wharton's jelly)autismneurology2016experimental therapyPoland8,5
293cord tissue (Wharton's jelly)sclerosis multiplexneurology2016experimental therapyPoland29,11
294cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland33,4
295cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland37,4
296cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland39,3
297cord tissue (Wharton's jelly)autismneurology2016experimental therapyPoland7,11
298cord tissue (Wharton's jelly)spinal cord injuryorthopedics2016experimental therapyPoland28
299cord tissue (Wharton's jelly)gonarthrosisorthopedics2016experimental therapyPoland69,6
300cord tissue (Wharton's jelly)spinal cord injuryorthopedics2016experimental therapyPoland33,11
301cord tissue (Wharton's jelly)spinal cord injuryorthopedics2016experimental therapyPoland20,7
302cord tissue (Wharton's jelly)spinal cord injuryorthopedics2016experimental therapyPoland24,5
303cord tissue (Wharton's jelly)spinal cord injuryorthopedics2016experimental therapyPoland25,6
304cord tissue (Wharton's jelly)autismneurology2016experimental therapyPoland8,5
305cord tissue (Wharton's jelly)facio-scapulo-humeral muscular dystrophyneurology2016experimental therapyPoland39,10
306cord tissue (Wharton's jelly)patella cartilage damageorthopedics2016experimental therapyPoland60,10
307cord tissue (Wharton's jelly)autismneurology2016experimental therapyPoland6,9
308cord tissue (Wharton's jelly)sclerosis multiplexneurology2016experimental therapyPoland44,8
309cord tissue (Wharton's jelly)facio-scapulo-humeral muscular dystrophyneurology2016experimental therapyPoland25,4
310cord tissue (Wharton's jelly)autismneurology2016experimental therapyPoland10,10
311cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland63,2
312cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland54,11
313cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland53,9
314cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland46,9
315cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland58
316cord tissue (Wharton's jelly)chronic graft versus host diseasehematology2016experimental therapyPoland19,2
317cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland55
318cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland58,1
319cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland61,7
320cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland52,6
321cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland59,11
322cord tissue (Wharton's jelly)tetraparesis spasticaorthopedics2016experimental therapyPoland28,8
323cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland60,9
324cord tissue (Wharton's jelly)spinal muscular atrophyneurology2016experimental therapyPoland34,9
325cord tissue (Wharton's jelly)gonarthrosisorthopedics2016experimental therapyPoland69,3
326cord tissue (Wharton's jelly)tetraparesis spasticaorthopedics2016experimental therapyPoland47,9
327cord tissue (Wharton's jelly)spinal cord injuryorthopedics2016experimental therapyPoland18,8
328cord tissue (Wharton's jelly)cerebral palsyneurology2016experimental therapyPoland2,9
329cord tissue (Wharton's jelly)traumatic brain injuryneurology2016experimental therapyPoland54,9
330cord tissue (Wharton's jelly)epilepsianeurology2016experimental therapyPoland19,5
331cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland59
332cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland66,9
333cord tissue (Wharton's jelly)tetraparesisorthopedics2016experimental therapyPoland27,9
334cord tissue (Wharton's jelly)epilepsianeurology2016experimental therapyPoland14,9
335cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland42,7
336cord tissue (Wharton's jelly)acute graft versus host diseasehematology2016experimental therapyPoland60,5
337cord tissue (Wharton's jelly)autismneurology2016experimental therapyPoland6,2
338cord tissue (Wharton's jelly)autismneurology2016experimental therapyPoland11,3
339cord tissue (Wharton's jelly)cerebral palsyneurology2016experimental therapyPoland9,11
340cord tissue (Wharton's jelly)gonarthrosisorthopedics2016experimental therapyPoland49,8
341cord tissue (Wharton's jelly)optic atrophyophthalmology2016experimental therapyPoland69,9
342cord tissue (Wharton's jelly)optic atrophyophthalmology2016experimental therapyPoland69,1
343cord tissue (Wharton's jelly)epilepsianeurology2016experimental therapyPoland13,11
344cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland45,1
345cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland53,4
346cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland36,1
347cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland59, 1
348cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland66,2
349cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland49,7
350cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland55,1
351cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland46,1
352cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland72,4
353cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland54,3
354cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland56,1
355cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland61,8
356cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland64,7
357cord tissue (Wharton's jelly)malformation syndromeneurology2016experimental therapyPoland3,5
358cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland64,2
359cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2016experimental therapyPoland38
360cord tissue (Wharton's jelly)autismneurology2016experimental therapyPoland6,10
361cord tissue (Wharton's jelly)encephalopathyneurology2016experimental therapyPoland2,11
362cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland62,8
363cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland56,5
364cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland51,3
365cord tissue (Wharton's jelly)cerebral palsyneurology2016experimental therapyPoland4,2
366cord tissue (Wharton's jelly)sclerosis multiplexneurology2016experimental therapyPoland55,4
367cord tissue (Wharton's jelly)sclerosis multiplexneurology2016experimental therapyPoland54,8
368cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland33,10
369cord tissue (Wharton's jelly)sclerosis multiplexneurology2016experimental therapyPoland41,4
370cord tissue (Wharton's jelly)sclerosis multiplexneurology2016experimental therapyPoland49,3
371cord tissue (Wharton's jelly)choroideremiaophthalmology2016experimental therapyPoland50,8
372cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2016experimental therapyPoland63,1
373cord tissue (Wharton's jelly)spinal cord injuryorthopedics2016experimental therapyPoland7,4
374cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland60,4
375cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland73,7
376cord tissue (Wharton's jelly)leukodystrophyneurology2016experimental therapyPoland2,11
377cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland61,6
378cord tissue (Wharton's jelly)spinal cord injuryorthopedics2016experimental therapyPoland48,3
379cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2016experimental therapyPoland32,7
380cord tissue (Wharton's jelly)acute graft versus host diseasehematology2016experimental therapyPoland3,11
381cord tissue (Wharton's jelly)sclerosis multiplexneurology2016experimental therapyPoland61,11
382cord tissue (Wharton's jelly)sclerosis multiplexneurology2016experimental therapyPoland45,8
383cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland61,4
384cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland79,2
385cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland72,6
386cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland48,4
387cord tissue (Wharton's jelly)adrenoleukodystrophyneurology2016experimental therapyPoland6,11
388cord tissue (Wharton's jelly)adrenoleukodystrophyneurology2016experimental therapyPoland9,7
389cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland54,2
390cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland50,9
391cord tissue (Wharton's jelly)limb-girdle muscular dystrophyneurology2016experimental therapyPoland22
392cord tissue (Wharton's jelly)epilepsianeurology2016experimental therapyPoland14,7
393cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland55,9
394cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland62,6
395cord tissue (Wharton's jelly)spinal cord injuryorthopedics2016experimental therapyPoland58,10
396cord tissue (Wharton's jelly)cerebral palsyneurology2016experimental therapyPoland12,6
397cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland66,2
398cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland55,9
399cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland49,4
400cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland55,7
401cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland58,1
402cord tissue (Wharton's jelly)spina bifidaneurology2016experimental therapyPoland4,8
403cord tissue (Wharton's jelly)spina bifidaneurology2016experimental therapyPoland1,5
404cord tissue (Wharton's jelly)cerebral palsyneurology2016experimental therapyPoland3
405cord tissue (Wharton's jelly)cerebral palsyneurology2016experimental therapyPoland9,9
406cord tissue (Wharton's jelly)global developmental delayneurology2016experimental therapyPoland6,9
407cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland66,8
408cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland39,6
409cord tissue (Wharton's jelly)autismneurology2016experimental therapyPoland13,2
410cord tissue (Wharton's jelly)developmental delayneurology2016experimental therapyPoland7,4
411cord tissue (Wharton's jelly)spina bifidaneurology2016experimental therapyPoland7,4
412cord tissue (Wharton's jelly)optic neuropathyophthalmology2016experimental therapyPoland66
413cord tissue (Wharton's jelly)sclerosis multiplexneurology2016experimental therapyPoland38,1
414cord tissue (Wharton's jelly)autismneurology2016experimental therapyPoland8,4
415cord tissue (Wharton's jelly)cerebral palsyneurology2016experimental therapyPoland3
416cord tissue (Wharton's jelly)optic neuropathyophthalmology2016experimental therapyPoland79,8
417cord tissue (Wharton's jelly)spinocerebellar ataxianeurology2016experimental therapyPoland54,3
418cord tissue (Wharton's jelly)dystrophia progressiva pseudohypertrophica /DMDneurology2016experimental therapyPoland14,4
419cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland47,11
420cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland49,3
421cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland61,2
422cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2016experimental therapyPoland23,6
423cord tissue (Wharton's jelly)age-related macular degenerationophthalmology2016experimental therapyPoland86,5
424cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2016experimental therapyPoland54,6
425cord tissue (Wharton's jelly)sclerosis multiplexneurology2016experimental therapyPoland68,5
426cord tissue (Wharton's jelly)cerebral palsyneurology2016experimental therapyPoland13,7
427cord tissue (Wharton's jelly)cerebral palsyneurology2016experimental therapyPoland2,2
428cord tissue (Wharton's jelly)autismneurology2016experimental therapyPoland5,0
429cord tissue (Wharton's jelly)cerebral palsyneurology2016experimental therapyPoland12,11
430cord tissue (Wharton's jelly)autismneurology2016experimental therapyPoland12,3
431cord tissue (Wharton's jelly)spina bifidaneurology2016experimental therapyPoland1,3
432cord tissue (Wharton's jelly)developmental delayneurology2016experimental therapyPoland2,7
433cord tissue (Wharton's jelly)spinal muscular atrophyneurology2016experimental therapyPoland3,3
434cord tissue (Wharton's jelly)facio-scapulo-humeral muscular dystrophyneurology2016experimental therapyPoland59,6
435cord tissue (Wharton's jelly)spinal muscular atrophyneurology2016experimental therapyPoland34,2
436cord tissue (Wharton's jelly)muscular dystrophyneurology2016experimental therapyPoland30,3
437cord tissue (Wharton's jelly)spinal muscular atrophyneurology2016experimental therapyPoland17,10
438cord tissue (Wharton's jelly)spinal cord injuryorthopedics2016experimental therapyPoland37,11
439cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland31,9
440cord tissue (Wharton's jelly)ataxia hereditarianeurology2016experimental therapyPoland69
441cord tissue (Wharton's jelly)muscular dystrophyneurology2016experimental therapyPoland31,9
442cord tissue (Wharton's jelly)no dataophthalmology2016experimental therapyPoland66,1
443cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland53,4
444cord tissue (Wharton's jelly)patella cartilage damageorthopedics2016experimental therapyPoland60,8
445cord tissue (Wharton's jelly)cerebral palsyneurology2016experimental therapyPoland10,8
446cord tissue (Wharton's jelly)encephalopathyneurology2016experimental therapyPoland3
447cord tissue (Wharton's jelly)spina bifidaneurology2016experimental therapyPoland2,11
448cord tissue (Wharton's jelly)encephalopathyneurology2016experimental therapyPoland4,3
449cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2016experimental therapyPolandno data
450cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2016experimental therapyPoland59,4
451cord tissue (Wharton's jelly)atrophy of the optic nervesophthalmology2016experimental therapyPoland20,11
452cord tissue (Wharton's jelly)patella cartilage damageorthopedics2016experimental therapyPoland53
453cord tissue (Wharton's jelly)autismneurology2016experimental therapyPoland24,5
454cord tissue (Wharton's jelly)dystrophia progressiva pseudohypertrophica /DMDneurology2016experimental therapyPoland34, 7
455cord tissue (Wharton's jelly)muscular dystrophyneurology2016experimental therapyPoland32,3
456cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland65,9
457cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland52,7
458cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland71,5
459cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2016experimental therapyPoland60,7
460cord tissue (Wharton's jelly)cerebral palsyneurology2016experimental therapyPoland1,10
461cord tissue (Wharton's jelly)cerebral palsyneurology2016experimental therapyPoland7,6
462cord tissue (Wharton's jelly)spinal muscular atrophyneurology2016experimental therapyPoland1,10
463cord tissue (Wharton's jelly)spinal cord injuryorthopedics2016experimental therapyPoland29,7
464cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland68,5
465cord tissue (Wharton's jelly)chronic graft versus host diseasehematology2016experimental therapyPoland8/12
466cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland44,5
467cord tissue (Wharton's jelly)dystrophia progressiva pseudohypertrophica /DMDneurology2016experimental therapyPoland9,2
468cord tissue (Wharton's jelly)Stargardt's diseaseophthalmology2016experimental therapyPoland24,5
469cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland66,7
470cord tissue (Wharton's jelly)spina bifidaneurology2016experimental therapyPoland15,9
471cord tissue (Wharton's jelly)cerebral palsyneurology2016experimental therapyPoland6,8
472cord tissue (Wharton's jelly)autismneurology2016experimental therapyPoland10,3
473cord tissue (Wharton's jelly)cerebral palsyneurology2016experimental therapyPoland16,4
474cord tissue (Wharton's jelly)autismneurology2016experimental therapyPoland6
475cord tissue (Wharton's jelly)spinocerebellar ataxianeurology2016experimental therapyPoland41,8
476cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland51,9
477cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland49,3
478cord tissue (Wharton's jelly)autismneurology2016experimental therapyPoland20,9
479cord tissue (Wharton's jelly)fetal alcohol spectrum disordersneurology2016experimental therapyPoland5,2
480cord tissue (Wharton's jelly)cerebral palsyneurology2016experimental therapyPoland13,10
481cord tissue (Wharton's jelly)tetraparesis spasticaorthopedics2016experimental therapyPoland58,4
482cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland68,2
483cord tissue (Wharton's jelly)chondronecrosis femoral condyleorthopedics2016experimental therapyPoland54,11
484cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland55,4
485cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland41,2
486cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland72,1
487cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland56,8
488cord tissue (Wharton's jelly)spina bifidaneurology2016experimental therapyPoland2,11
489cord tissue (Wharton's jelly)tetraparesis spasticaorthopedics2016experimental therapyPoland18
490cord tissue (Wharton's jelly)cerebral palsyneurology2016experimental therapyPoland4,1
491cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland48,1
492cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland56,3
493cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland66,10
494cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPolandno data
495cord tissue (Wharton's jelly)gangliosidosis t. 1neurology2016experimental therapyPoland1,4
496cord tissue (Wharton's jelly)epilepsianeurology2016experimental therapyPoland14,9
497cord tissue (Wharton's jelly)epileptic encephalopathyneurology2016experimental therapyPoland3,6
498cord tissue (Wharton's jelly)polineuropathyneurology2016experimental therapyPoland70,8
499cord tissue (Wharton's jelly)diffuse cartilage damage left medial compartment of the kneeorthopedics2016experimental therapyPoland50,5
500cord tissue (Wharton's jelly)Stargardt's diseaseophthalmology2016experimental therapyPoland37,7
501cord tissue (Wharton's jelly)myopia, hyperopia, astigmatism, abnormal refraction and accommodation, optic atrophyophthalmology2016experimental therapyPoland37,1
502cord tissue (Wharton's jelly)optic neuropathyophthalmology2016experimental therapyPoland33,5
503cord tissue (Wharton's jelly)epilepsianeurology2016experimental therapyPoland16,2
504cord tissue (Wharton's jelly)cerebral palsyneurology2016experimental therapyPoland3,7
505cord tissue (Wharton's jelly)spinal cord injuryorthopedics2016experimental therapyPoland17,9
506cord tissue (Wharton's jelly)injuries to the spinal nervesneurology2016experimental therapyPoland5/12
507cord tissue (Wharton's jelly)cartilage damageorthopedics2016experimental therapyPoland57,6
508cord tissue (Wharton's jelly)dystrophia progressiva pseudohypertrophica /DMDneurology2016experimental therapyPoland4,8
509cord tissue (Wharton's jelly)muscular dystrophyneurology2016experimental therapyPoland44,7
510cord tissue (Wharton's jelly)dystrophia progressiva pseudohypertrophica /DMDneurology2016experimental therapyPoland10
511cord tissue (Wharton's jelly)cerebral palsyneurology2016experimental therapyPoland4,4
512cord tissue (Wharton's jelly)spina bifidaneurology2016experimental therapyPoland4,9
513cord tissue (Wharton's jelly)cerebellar syndromeneurology2016experimental therapyPoland28,6
514cord tissue (Wharton's jelly)neurodevelopmental disordersneurology2016experimental therapyPoland4,5
515cord tissue (Wharton's jelly)tetraparesisorthopedics2016experimental therapyPoland27,2
516cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland61,2
517cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2016experimental therapyPoland44,8
518cord tissue (Wharton's jelly)degeneration of the cartilage of the knee jointorthopedics2016experimental therapyPoland54,3
519cord tissue (Wharton's jelly)dystrophia progressiva pseudohypertrophica /BMDneurology2016experimental therapyPoland19,2
520cord tissue (Wharton's jelly)facio-scapulo-humeral muscular dystrophyneurology2016experimental therapyPoland15,0
521cord tissue (Wharton's jelly)facio-scapulo-humeral muscular dystrophyneurology2016experimental therapyPoland31,11
522cord tissue (Wharton's jelly)facio-scapulo-humeral muscular dystrophyneurology2016experimental therapyPoland33,4
523cord tissue (Wharton's jelly)endometrial atrophyginecology2016experimental therapyPoland37,3
524cord tissue (Wharton's jelly)endometrial atrophyginecology2016experimental therapyPoland39,1
525cord tissue (Wharton's jelly)sclerosis multiplexneurology2016experimental therapyPoland38,4
526cord tissue (Wharton's jelly)spinal cord injuryorthopedics2016experimental therapyPoland44,5
527cord tissue (Wharton's jelly)meniscus damageorthopedics2016experimental therapyPoland35,5
528cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland60,8
529cord tissue (Wharton's jelly)premature ovarian failureginecology2016experimental therapyPoland23,4
530cord tissue (Wharton's jelly)premature ovarian failureginecology2016experimental therapyPoland34,9
531cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2016experimental therapyPoland55,5
532bone marrowosteopetrosismetabolic2016standard therapyRussia6
533bone marrowsevere combined immunodeficiencyhematology2016standard therapyRomania2
534bone marrowT-cell acute lymphoblastic leukemiahematology2016standard therapyItaly4
535bone marrowno datan/a2016standard therapyItaly3
536bone marrowacute myelogenous leukemiahematology2016standard therapyItaly64
537bone marrowacute lymphoblastic leukemiahematology2016standard therapyItaly9
538bone marrowacute myelogenous leukemiahematology2016standard therapySpain55
539bone marrowFanconi anaemiahematology2016standard therapyEstonia7
540bone marrowacute lymphoblastic leukemiahematology2016standard therapyItaly6
541bone marrowacute myelogenous leukemiahematology2016standard therapyItaly64
542bone marrowacute lymphoblastic leukemiahematology2016standard therapyItaly14
543bone marrowbiphenotypic leukemiahematology2016standard therapyBrazil27
544bone marrowacute lymphoblastic leukemiahematology2016standard therapyGermany7
545bone marrowosteopetrosismetabolic2016standard therapyGermany1
546bone marrowsevere aplastic anaemiahematology2016standard therapyFrance9
547bone marrowno datan/a2016standard therapyPoland7
548bone marrowHurler syndromemetabolic2016standard therapyUnited Kingdom2
549bone marrow severe combined immunodeficiencyhematology2016standard therapyTurkey4
550bone marrowacute lymphoblastic leukemiahematology2016standard therapyCanada11
551bone marrowmyelofibrosishematology2016standard therapyGermany31
552bone marrowDiGeorge syndromehematology2016standard therapyNetherlands24
553bone marrowHodgkin’s lymphomahematology2016standard therapyItaly17
554bone marrowacute myelogenous leukemiahematology2016standard therapyBelarus12
555bone marrowacute lymphoblastic leukemiahematology2016standard therapyBelarus18
556bone marrowsevere combined immunodeficiencyhematology2016standard therapyPoland7/12
557bone marrowsevere aplastic anaemiahematology2016standard therapyFrance9
558bone marrowsevere aplastic anaemia / paroxymal nocturnal haemoglobinuriahematology2016standard therapyPoland17
559bone marrowmyelodysplastic syndromehematology2016standard therapyHungary1
560bone marrowacute myelogenous leukemiahematology2016standard therapyItaly67
561bone marrowmyelodysplastic syndromehematology2016standard therapySpain56
562bone marrowFanconi anaemiahematology2016standard therapyNetherlands41
563bone marrowacute lymphoblastic leukemiahematology2016standard therapyFrance5
564bone marrowacute myelogenous leukemiahematology2016standard therapyUnited Kingdom29
565bone marrowacute lymphoblastic leukemiahematology2016standard therapyBelarus25
566bone marrowacute lymphoblastic leukemiahematology2016standard therapyNew Zealand1
567bone marrowsevere combined immunodeficiencyhematology2016standard therapyGermany12
568bone marrowacute lymphoblastic leukemiahematology2016standard therapyPoland5
569bone marrowno datan/a2016standard therapyPoland33
570bone marrownon-Hodgkin lymphomahematology2016standard therapyItaly46
571bone marrowaplastic anaemiahematology2016standard therapyAustria20
572bone marrowacute myelogenous leukemiahematology2016standard therapyCroatia33
573bone marrowmyeloproliferative syndromehematology2016standard therapyPoland22
574bone marrowacute myelogenous leukemiahematology2016standard therapyIreland39
575bone marrowDiamond-Balckfan anaemiahematology2016standard therapyGermany2
576bone marrowacute myelogenous leukemiahematology2016standard therapyCzech Republic9
577bone marrowacute lymphoblastic leukemiahematology2016standard therapyBelarus15
578bone marrowjuvenile myelomonocytic leukemiahematology2016standard therapyGermany3
579bone marrowacute myelogenous leukemiahematology2016standard therapyFinland45
580bone marrowanaemiahematology2016standard therapyGermany16
581bone marrowacute lymphoblastic leukemiahematology2016standard therapyGermany6
582bone marrowanaemiahematology2016standard therapyItaly5
583bone marrowhigh-risk acute lymphoblastic leukemiahematology2016standard therapyPoland18
584cord tissue (Wharton's jelly)acute graft versus host diseasehematology2015experimental therapyPoland1,4
585cord tissue (Wharton's jelly)autismneurology2015experimental therapyPoland5,4
586cord tissue (Wharton's jelly)sclerosis multiplexneurology2015experimental therapyPoland23,2
587cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2015experimental therapyPoland61,6
588cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2015experimental therapyPoland61
589cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2015experimental therapyPoland56
590cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2015experimental therapyPoland51
591cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2015experimental therapyPoland65
592cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2015experimental therapyPoland60
593cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2015experimental therapyPoland52
594cord tissue (Wharton's jelly)cerebral palsyneurology2015experimental therapyPoland3,8
595cord tissue (Wharton's jelly)decerebration rigidityneurology2015experimental therapyPoland9,6
596cord tissue (Wharton's jelly)bilateral blindnessophthalmology2015experimental therapyPoland36,10
597cord tissue (Wharton's jelly)acute graft versus host diseasehematology2015experimental therapyPoland11/12
598cord tissue (Wharton's jelly)cerebral palsyneurology2015experimental therapyPoland7,1
599cord tissue (Wharton's jelly)cerebral palsyneurology2015experimental therapyPoland15,8
600cord tissue (Wharton's jelly)ceroid lipofuscinosisneurology2015experimental therapyPoland5,1
601cord tissue (Wharton's jelly)encephalopathyneurology2015experimental therapyPoland14,5
602cord tissue (Wharton's jelly)ceroid lipofuscinosisneurology2015experimental therapyPoland7,10
603cord tissue (Wharton's jelly)autismneurology2015experimental therapyPoland3
604cord tissue (Wharton's jelly)cerebral palsyneurology2015experimental therapyPoland7,1
605cord tissue (Wharton's jelly)cerebral palsyneurology2015experimental therapyPoland13,1
606cord tissue (Wharton's jelly)spina bifidaneurology2015experimental therapyPoland2,4
607cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2015experimental therapyPoland59,4
608cord tissue (Wharton's jelly)spinal cord injuryorthopedics2015experimental therapyPoland31,2
609cord tissue (Wharton's jelly)cerebral palsyneurology2015experimental therapyPoland5,1
610cord tissue (Wharton's jelly)autismneurology2015experimental therapyPoland12,5
611cord tissue (Wharton's jelly)cerebral palsyneurology2015experimental therapyPoland8,11
612cord tissue (Wharton's jelly)delayed psychomotor development, deafnessneurology2015experimental therapyPoland3,3
613cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2015experimental therapyPoland61,5
614cord tissue (Wharton's jelly)traumatic encephalopathyneurology2015experimental therapyPoland20,11
615cord tissue (Wharton's jelly)spinal cord injuryorthopedics2015experimental therapyPoland18,8
616cord tissue (Wharton's jelly)cerebral palsyneurology2015experimental therapyPoland2,7
617cord tissue (Wharton's jelly)adrenoleukodystrophy; encephalopathyneurology2015experimental therapyPoland23
618cord tissue (Wharton's jelly)adrenoleukodystrophyneurology2015experimental therapyPoland11,11
619cord tissue (Wharton's jelly)spinal cord injuryorthopedics2015experimental therapyPoland40
620cord tissue (Wharton's jelly)spinal cord injuryorthopedics2015experimental therapyPoland26,1
621cord tissue (Wharton's jelly)spinal cord injuryorthopedics2015experimental therapyPoland37,1
622cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2015experimental therapyPoland58
623cord tissue (Wharton's jelly)spinocerebellar ataxianeurology2015experimental therapyPoland35,6
624cord tissue (Wharton's jelly)spinal muscular atrophyneurology2015experimental therapyPoland11/12
625cord tissue (Wharton's jelly)spinocerebellar ataxianeurology2015experimental therapyPoland44,6
626cord tissue (Wharton's jelly)optic neuropathyophthalmology2015experimental therapyPoland15,8
627cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2015experimental therapyPoland61,6
628cord tissue (Wharton's jelly)gonarthrosisorthopedics2015experimental therapyPoland66,2
629cord tissue (Wharton's jelly)iatrogenic spinal cord injuryneurology2015experimental therapyPoland17,2
630cord tissue (Wharton's jelly)optic neuropathyophthalmology2015experimental therapyPoland45,10
631cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2015experimental therapyPoland62
632cord tissue (Wharton's jelly)acute graft versus host diseasehematology2015experimental therapyPoland51,5
633cord tissue (Wharton's jelly)cerebral palsyneurology2015experimental therapyPoland12,10
634cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2015experimental therapyPoland26,5
635cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2015experimental therapyPoland27
636cord tissue (Wharton's jelly)cerebral palsyneurology2015experimental therapyPoland4,10
637cord tissue (Wharton's jelly)autismneurology2015experimental therapyPoland6,1
638cord tissue (Wharton's jelly)autismneurology2015experimental therapyPoland4,6
639cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2015experimental therapyPoland63,11
640cord tissue (Wharton's jelly)spinal cord injuryorthopedics2015experimental therapyPoland32,10
641cord tissue (Wharton's jelly)cerebral palsyneurology2015experimental therapyPoland22
642cord tissue (Wharton's jelly)sclerosis multiplexneurology2015experimental therapyPoland33,3
643cord tissue (Wharton's jelly)delayed psychomotor developmentneurology2015experimental therapyPoland3,6
644cord tissue (Wharton's jelly)spina bifidaneurology2015experimental therapyPoland2
645cord tissue (Wharton's jelly)cerebellar ataxianeurology2015experimental therapyPoland18,7
646cord tissue (Wharton's jelly)spinocerebellar ataxianeurology2015experimental therapyPoland24,3
647cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2015experimental therapyPoland67,6
648cord tissue (Wharton's jelly)autismneurology2015experimental therapyPoland5,6
649cord tissue (Wharton's jelly)polineuropathyneurology2015experimental therapyPoland74,2
650cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2015experimental therapyPoland37,6
651cord tissue (Wharton's jelly)strokeneurology2015experimental therapyPoland62,8
652cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2015experimental therapyPoland58,10
653cord tissue (Wharton's jelly)facio-scapulo-humeral muscular dystrophyneurology2015experimental therapyPoland30,1
654cord tissue (Wharton's jelly)chronic graft versus host diseasehematology2015experimental therapyPoland10
655cord tissue (Wharton's jelly)severe developmental delayneurology2015experimental therapyPoland1,1
656cord tissue (Wharton's jelly)spinal muscular atrophyneurology2015experimental therapyPoland26,2
657cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2015experimental therapyPoland46,2
658cord tissue (Wharton's jelly)autismneurology2015experimental therapyPoland8,7
659cord tissue (Wharton's jelly)encephalopathyneurology2015experimental therapyPoland8/12
660cord tissue (Wharton's jelly)acute graft versus host diseasehematology2015experimental therapyPoland6,6
661cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2015experimental therapyPoland48,7
662cord tissue (Wharton's jelly)spinal cord injuryorthopedics2015experimental therapyPoland21,4
663cord tissue (Wharton's jelly)cerebral palsyneurology2015experimental therapyPoland9,9
664cord tissue (Wharton's jelly)acute graft versus host diseasehematology2015experimental therapyPoland13,4
665cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2015experimental therapyPoland61,3
666cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2015experimental therapyPoland54
667cord tissue (Wharton's jelly)intracranial injuryneurology2015experimental therapyPoland24,3
668cord tissue (Wharton's jelly)strokeneurology2015experimental therapyPoland54,9
669cord tissue (Wharton's jelly)spinal cord injuryorthopedics2015experimental therapyPoland24,7
670cord tissue (Wharton's jelly)gonarthrosisorthopedics2015experimental therapyPoland65,9
671cord tissue (Wharton's jelly)leukodystrophyneurology2015experimental therapyPoland18,8
672cord tissue (Wharton's jelly)spinal cord injuryorthopedics2015experimental therapyPoland34,4
673cord tissue (Wharton's jelly)cerebral palsyneurology2015experimental therapyPoland1,6
674cord tissue (Wharton's jelly)cerebral palsyneurology2015experimental therapyPoland14,10
675cord tissue (Wharton's jelly)anterior ischemic optic neuropathyophthalmology2015experimental therapyPoland54,10
676cord tissue (Wharton's jelly)cerebral palsyneurology2015experimental therapyPoland16,9
677cord tissue (Wharton's jelly)retinitis pigmentosaophthalmology2015experimental therapyPoland34,5
678cord tissue (Wharton's jelly)cerebellar ataxianeurology2015experimental therapyPoland26,1
679cord tissue (Wharton's jelly)encephalopathyneurology2015experimental therapyPoland11,2
680cord tissue (Wharton's jelly)adrenoleukodystrophy; encephalopathyneurology2015experimental therapyPoland8,4
681cord tissue (Wharton's jelly)neuropathyneurology2014experimental therapyPoland23,6
682cord tissue (Wharton's jelly)autismneurology2014experimental therapyPoland12,6
683cord tissue (Wharton's jelly)acute graft versus host diseasehematology2014experimental therapyPoland6
684cord tissue (Wharton's jelly)central motor coordination impairment after hypoxic ischaemia lesion at birthneurology2014experimental therapyPoland2,1
685cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2014experimental therapyPoland60,10
686cord tissue (Wharton's jelly)amyotrophic lateral sclerosisneurology2014experimental therapyPoland24,1
687cord tissue (Wharton's jelly)autismneurology2014experimental therapyPoland8,3
688cord tissue (Wharton's jelly)muscular dystrophyneurology2014experimental therapyPoland6
689cord tissue (Wharton's jelly)birth asphyxia; retinopathyneurology2014experimental therapyPoland11/12
690cord tissue (Wharton's jelly)cerebral palsyneurology2014experimental therapyPoland4,10
691cord tissue (Wharton's jelly)cerebral palsyneurology2014experimental therapyPoland15,10
692cord tissue (Wharton's jelly)acute graft versus host diseasehematology2013experimental therapyPoland18,9
693cord tissue (Wharton's jelly)acute graft versus host diseasehematology2013experimental therapyPoland2,11
694cord tissue (Wharton's jelly)acute graft versus host diseasehematology2013experimental therapyPoland3,5
695cord tissue (Wharton's jelly)acute myeloid leukemiahematology2013experimental therapyPoland3,5
696cord tissue (Wharton's jelly)chronic graft versus host diseasehematology2013experimental therapyPoland18,8
697cord tissue (Wharton's jelly)chronic graft versus host diseasehematology2013experimental therapyPoland17,5
698cord tissue (Wharton's jelly)acute graft versus host diseasehematology2012experimental therapyPoland19,7
699cord tissue (Wharton's jelly)acute graft versus host diseasehematology2012experimental therapyPoland7,1
700cord tissue (Wharton's jelly)acute graft versus host diseasehematology2012experimental therapyPoland4,3
701cord tissue (Wharton's jelly)acute graft versus host diseasehematology2011experimental therapyPoland17,2
702peripheral bloodHurler syndromehematology2017standard therapyUnited Kingdom2
703peripheral bloodmyeloma multiplexhematology2017standard therapyGermany44
704peripheral bloodmyelodysplastic syndromehematology2017standard therapyPoland60
705peripheral bloodacute lymphoblastic leukemiahematology2017standard therapyUSA24
706peripheral bloodacute myelogenous leukemiahematology2017standard therapyUnited Kingdom51
707peripheral bloodchronic myeloproliferative neoplasm blast crisishematology2017standard therapyGermany29
708peripheral bloodacute lymphoblastic leukemiahematology2017standard therapyPoland43
709peripheral bloodmyelodysplastic syndromehematology2017standard therapyFrance68
710peripheral bloodchronic myeloid leukemiahematology2017standard therapyTurkey29
711peripheral bloodsevere aplastic anaemiahematology2017standard therapyPoland14
712peripheral bloodNiemann–Pick diseasehematology2017standard therapyPoland2
713peripheral bloodacute lymphoblastic leukemiahematology2017standard therapyIran17
714peripheral bloodmyelodysplastic syndromehematology2017standard therapyPoland3
715peripheral bloodnon-Hodgkin lymphomahematology2017standard therapyUSA63
716peripheral bloodCommon variable immunodeficiency, relapsed hemophagocytic syndromehematology2017standard therapyGermany44
717peripheral bloodacute myelogenous leukemiahematology2017standard therapyFrance65
718peripheral bloodmyelofibrosishematology2017standard therapySpain63
719peripheral blooddiffuse large B-cell lymphomahematology2017standard therapyGermany61
720peripheral bloodmyelodysplastic syndromehematology2017standard therapyUSA56
721peripheral bloodacute myelogenous leukemiahematology2017standard therapyItaly48
722peripheral bloodmyelodysplastic syndromehematology2017standard therapyAustria54
723peripheral bloodmyelofibrosishematology2017standard therapyDenmark63
724peripheral bloodacute myelogenous leukemiahematology2017standard therapyHungary47
725peripheral bloodno datan/a2017standard therapyFrance39
726peripheral bloodacute myelogenous leukemiahematology2017standard therapyPoland54
727peripheral bloodLangerhans Lymphohistiocytosishematology2017standard therapyCzech Republic2
728peripheral bloodmyelodysplastic syndromehematology2017standard therapyUSA75
729peripheral bloodmyelodysplastic syndromehematology2017standard therapySlovakia64
730peripheral bloodchronic lymphocytic leukemiahematology2017standard therapyBelgium57
731peripheral bloodacute myelogenous leukemiahematology2017standard therapyRussia32
732peripheral bloodacute lymphoblastic leukemiahematology2017standard therapyUSA53
733peripheral bloodacute myelogenous leukemiahematology2017standard therapyGermany47
734peripheral bloodacute lymphoblastic leukemiahematology2017standard therapyFrance43
735peripheral bloodacute myelogenous leukemiahematology2017standard therapyItaly48
736peripheral bloodnon-Hodgkin lymphomahematology2017standard therapyFrance56
737peripheral bloodnon-Hodgkin lymphomahematology2017standard therapyItaly47
738peripheral bloodacute lymphoblastic leukemiahematology2017standard therapyPoland3
739peripheral bloodacute myelogenous leukemiahematology2017standard therapySpain20
740peripheral bloodmyelodysplastic syndromehematology2017standard therapyCroatia64
741peripheral bloodmyelofibrosishematology2017standard therapyGermany66
742peripheral bloodacute myelogenous leukemiahematology2017standard therapyUSA44
743peripheral bloodmyelodysplastic syndromehematology2017standard therapyPoland46
744peripheral bloodmyelodysplastic syndromehematology2017standard therapyUSA53
745peripheral bloodacute myelogenous leukemiahematology2017standard therapyNetherlands66
746peripheral bloodacute myelogenous leukemiahematology2017standard therapyNetherlands75
747peripheral bloodacute myelogenous leukemiahematology2017standard therapyItaly61
748peripheral bloodacute myelogenous leukemiahematology2017standard therapySweden63
749peripheral bloodacute myelogenous leukemiahematology2017standard therapyPoland60
750peripheral bloodmyeloma multiplexhematology2017standard therapyGermany56
751peripheral bloodacute myelogenous leukemiahematology2017standard therapyLithuania59
752peripheral bloodacute myelogenous leukemiahematology2017standard therapyItaly45
753peripheral bloodhemophagocytosishematology2017standard therapyUSA52
754peripheral bloodacute lymphoblastic leukemiahematology2017standard therapyBrazil12
755peripheral bloodnon-Hodgkin lymphomahematology2017standard therapyNorway57
756peripheral bloodacute lymphoblastic leukemiahematology2017standard therapyBelgium19
757peripheral bloodchronic lymphocytic leukemiahematology2017standard therapyUSA45
758peripheral bloodnon-Hodgkin lymphomahematology2017standard therapyUSA65
759peripheral bloodacute myelogenous leukemiahematology2017standard therapyGermany64
760peripheral bloodmyelodysplastic syndromehematology2017standard therapyBelgium71
761peripheral bloodacute myelogenous leukemiahematology2017standard therapyTurkey46
762peripheral bloodacute myelogenous leukemiahematology2017standard therapyBelgium55
763peripheral bloodno datahematology2017standard therapyPoland39
764peripheral bloodaplastic anaemiahematology2017standard therapyUnited Kingdom23
765peripheral bloodmyelofibrosishematology2017standard therapyUSA62
766peripheral bloodmyelodysplastic syndromehematology2017standard therapyGermany50
767peripheral bloodacute myelogenous leukemiahematology2017standard therapyCanada57
768peripheral bloodnon-Hodgkin lymphomahematology2017standard therapyItaly58
769peripheral bloodchronic myelomonocytic leukaemiahematology2017standard therapyGermany54
770peripheral bloodacute myelogenous leukemiahematology2017standard therapyItaly32
771peripheral bloodacute myelogenous leukemiahematology2017standard therapyFrance75
772peripheral bloodnon-Hodgkin lymphomahematology2017standard therapyUSA42
773peripheral bloodmyelodysplastic syndromehematology2017standard therapyUSA63
774peripheral bloodacute lymphoblastic leukemiahematology2017standard therapyAustralia60
775peripheral bloodacute myelogenous leukemiahematology2017standard therapyGermany53
776peripheral bloodmyelodysplastic syndromehematology2017standard therapyGermany67
777peripheral bloodacute lymphoblastic leukemiahematology2017standard therapyUSA33
778peripheral bloodacute myelogenous leukemiahematology2017standard therapyPoland64
779peripheral bloodnon-Hodgkin lymphomahematology2017standard therapyGermany56
780peripheral bloodacute myelogenous leukemiahematology2017standard therapyGermany65
781peripheral bloodB-cell Chronic lymphoblastic leukemiahematology2017standard therapyGermany48
782peripheral bloodchronic lymphocytic leukemiahematology2017standard therapyPoland47
783peripheral bloodosteopetrosishematology2017standard therapyIsrael3
784peripheral bloodacute myelogenous leukemiahematology2017standard therapyFrance56
785peripheral bloodacute myelogenous leukemiahematology2017standard therapyItaly55
786peripheral bloodacute lymphoblastic leukemiahematology2017standard therapyCanada56
787peripheral bloodmyelodysplastic syndromehematology2017standard therapyLithuania65
788peripheral bloodacute myelogenous leukemiahematology2017standard therapySwitzerland75
789peripheral bloodacute myelogenous leukemiahematology2017standard therapyUSA69
790peripheral bloodacute myelogenous leukemiahematology2017standard therapyUSA51
791peripheral bloodT-cell Acute lymphoblastic leukemiahematology2017standard therapyAustralia30
792peripheral bloodchronic lymphocytic leukemiahematology2017standard therapyEstonia67
793peripheral bloodacute myelogenous leukemiahematology2017standard therapyUSA70
794peripheral bloodacute myelogenous leukemiahematology2017standard therapyBelgium34
795peripheral bloodmyelodysplastic syndromehematology2017standard therapyUSA68
796peripheral bloodmyeloproliferative neoplasmshematology2017standard therapyPoland7
797peripheral bloodacute myelogenous leukemiahematology2017standard therapyPoland52
798peripheral bloodacute lymphoblastic leukemiahematology2017standard therapyPoland59
799peripheral bloodmyelofibrosishematology2017standard therapyUnited Kingdom55
800peripheral bloodacute myelogenous leukemiahematology2017standard therapyPoland62
801peripheral bloodmyelodysplastic syndromehematology2017standard therapyPoland59
802peripheral bloodacute myelogenous leukemiahematology2017standard therapyCanada67
803peripheral bloodacute myelogenous leukemiahematology2017standard therapyUSA67
804peripheral bloodβ - Thalassemia Majorhematology2017standard therapyIndia4
805peripheral bloodacute myelogenous leukemiahematology2017standard therapyCzech Republic48
806peripheral bloodacute myelogenous leukemiahematology2017standard therapyPoland53
807peripheral bloodacute myelogenous leukemiahematology2017standard therapyGermany55
808peripheral bloodacute myelogenous leukemiahematology2017standard therapyCzech Republic62
809peripheral bloodacute myelogenous leukemia with myelodysplastic syndromehematology2017standard therapyGermany64
810peripheral bloodfollicular CAhematology2017standard therapySouth Africa42
811peripheral bloodmyelodysplastic syndromehematology2017standard therapyCanada63
812peripheral bloodchronic lymphocytic leukemiahematology2017standard therapyUSA65
813peripheral bloodacute lymphoblastic leukemiahematology2017standard therapyUSA35
814peripheral bloodother myleofibrosishematology2017standard therapyUSA71
815peripheral bloodacute myelogenous leukemiahematology2017standard therapyUSA64
816peripheral bloodmyelodysplastic syndromehematology2017standard therapyUSA69
817peripheral bloodacute myelogenous leukemiahematology2017standard therapyItaly39
818peripheral bloodmyelodysplastic syndromehematology2017standard therapyUSA54
819peripheral bloodprolymphocytic leukemiahematology2017standard therapyBelgium38
820peripheral bloodmyelodysplastic syndromehematology2017standard therapyFrance65
821peripheral bloodacute lymphoblastic leukemiahematology2017standard therapyUSA23
822peripheral bloodacute myelogenous leukemiahematology2017standard therapySlovakia54
823peripheral bloodacute myelogenous leukemiahematology2017standard therapyPoland35
824peripheral bloodacute myelogenous leukemiahematology2017standard therapyFinland46
825peripheral bloodmyelofibrosishematology2017standard therapyGermany29
826peripheral bloodmyelodysplastic syndromehematology2017standard therapyGermany63
827peripheral bloodacute lymphoblastic leukemiahematology2017standard therapyCzech Republic12
828peripheral bloodacute myelogenous leukemiahematology2017standard therapyGermany29
829peripheral bloodno datahematology2017standard therapyGermany65
830peripheral bloodchronic granulomatous diseasehematology2017standard therapyPoland4
831peripheral bloodno datahematology2017standard therapyRussia36
832peripheral bloodacute myelogenous leukemiahematology2017standard therapyTurkey58
833peripheral bloodmyelodysplastic syndromehematology2017standard therapyTurkey54
834peripheral bloodacute lymphoblastic leukemiahematology2017standard therapyNetherlands51
835peripheral bloodacute myelogenous leukemiahematology2017standard therapyGermany60
836peripheral bloodmyelodysplastic syndromehematology2017standard therapyGermany49
837peripheral bloodacute lymphoblastic leukemiahematology2017standard therapyPoland38
838peripheral bloodacute myelogenous leukemiahematology2017standard therapyPoland38
839peripheral bloodacute myelogenous leukemiahematology2017standard therapyHungary32
840peripheral bloodnon-Hodgkin lymphomahematology2017standard therapyPoland36
841peripheral bloodT-cell Acute lymphoblastic leukemiahematology2017standard therapyPoland7
842peripheral bloodmyelofibrosishematology2017standard therapyUSA62
843peripheral bloodno datahematology2017standard therapyKanada32
844peripheral bloodacute myelogenous leukemiahematology2017standard therapyFrance63
845peripheral bloodnon-Hodgkin lymphomahematology2017standard therapyFrance63
846peripheral bloodprimary Immunodeficiencyhematology2017standard therapyRussia4
847peripheral bloodmyelodysplastic syndromehematology2017standard therapyFrance39
848peripheral bloodacute lymphoblastic leukemiahematology2017standard therapyUSA62
849peripheral bloodacute myelogenous leukemiahematology2017standard therapyUSA65
850peripheral bloodchronic myelomonocytic leukaemiahematology2017standard therapyUSA58
851peripheral bloodacute myelogenous leukemiahematology2017standard therapyItaly67
852peripheral bloodacute myelogenous leukemiahematology2017standard therapyUSA58
853peripheral bloodacute lymphoblastic leukemiahematology2017standard therapyNetherlands51
854peripheral bloodmyelodysplastic syndromehematology2017standard therapyUSA69
855peripheral bloodacute lymphoblastic leukemiahematology2017standard therapyPoland19
856peripheral bloodmyelodysplastic syndromehematology2017standard therapySwitzerland67
857peripheral bloodacute myelogenous leukemiahematology2017standard therapyPoland43
858peripheral bloodnon-Hodgkin lymphomahematology2017standard therapyUSA68
859peripheral bloodmyelodysplastic syndromehematology2017standard therapyAmsterdam69
860peripheral bloodacute lymphoblastic leukemiahematology2017standard therapyIsrael11
861peripheral bloodacute lymphoblastic leukemiahematology2017standard therapyCanada4
862peripheral bloodacute myelogenous leukemiahematology2017standard therapyPoland42
863peripheral bloodmyeloproliferative neoplasmshematology2017standard therapyPoland7
864peripheral bloodno datahematology2017standard therapyPoland58
865peripheral bloodacute myelogenous leukemiahematology2016standard therapyUnited Kingdom58
866peripheral bloodacute lymphoblastic leukemiahematology2016standard therapyPoland56
867peripheral bloodmyelodysplastic syndromehematology2016standard therapyAustria60
868peripheral bloodacute myelogenous leukemiahematology2016standard therapyAustralia62
869peripheral bloodno datan/a2016standard therapyCzech Republic45
870peripheral bloodchronic lymphocytic leukemiahematology2016standard therapySlovakia52
871peripheral bloodacute myelogenous leukemiahematology2016standard therapyFrance40
872peripheral bloodno datan/a2016standard therapyNetherlands70
873peripheral bloodno datan/a2016standard therapyPoland43
874peripheral bloodacute myelogenous leukemiahematology2016standard therapyPoland18
875peripheral bloodX-linked lymphoproliferative diseasehematology2016standard therapyRussia12
876peripheral bloodchronic lymphocytic leukemiahematology2016standard therapySweden61
877peripheral bloodacute myelogenous leukemiahematology2016standard therapyGermany66
878peripheral bloodno datan/a2016standard therapyNetherlands69
879peripheral bloodacute lymphoblastic leukemiahematology2016standard therapyColumbia43
880peripheral bloodacute myelogenous leukemiahematology2016standard therapyGermany64
881peripheral bloodHodgkin’s lymphomahematology2016standard therapyPoland31
882peripheral bloodacute myelogenous leukemiahematology2016standard therapyCzech Republic54
883peripheral bloodT-cell leukemia/lymphomahematology2016standard therapyCanada31
884peripheral bloodacute myelogenous leukemiahematology2016standard therapyPoland54
885peripheral bloodprimary myelofibrosishematology2016standard therapyGermany50
886peripheral bloodacute myelogenous leukemiahematology2016standard therapyPoland18
887peripheral bloodadrenoleukodystrophymetabolic2016standard therapyPoland1
888peripheral bloodacute myelogenous leukemiahematology2016standard therapyItaly31
889peripheral bloodno datan/a2016standard therapyPoland28
890peripheral bloodacute myelogenous leukemiahematology2016standard therapySweden35
891peripheral bloodno datan/a2016standard therapyCzech Republic1
892peripheral bloodWiskott-Aldrich syndromehematology2016standard therapyPoland1
893peripheral bloodno datan/a2016standard therapyBelgium30
894peripheral bloodno datan/a2016standard therapyGermany71
895peripheral bloodacute myelogenous leukemiahematology2016standard therapyGermany46
896peripheral bloodacute myelogenous leukemiahematology2016standard therapyGermany29
897peripheral bloodmyelodysplastic syndromehematology2016standard therapyCzech Republic56
898peripheral bloodacute myelogenous leukemiahematology2016standard therapyFrance32
899peripheral bloodacute myelogenous leukemiahematology2016standard therapyCzech Republic49
900peripheral bloodmyelodysplastic syndromehematology2016standard therapyGermany50
901peripheral bloodacute myelogenous leukemiahematology2016standard therapyPoland64
902peripheral bloodacute myelogenous leukemiahematology2016standard therapyPoland42
903peripheral bloodacute myelogenous leukemiahematology2016standard therapyGermany13
904peripheral bloodacute myelogenous leukemiahematology2016standard therapySlovakia8
905peripheral bloodacute myelogenous leukemiahematology2016standard therapyBelgium46
906peripheral bloodrefractory anemia with excess blastshematology2016standard therapyUnited Kingdom62
907peripheral bloodacute myelogenous leukemiahematology2016standard therapyPoland40
908peripheral bloodmyelodysplastic syndrome - RAEBhematology2016standard therapyPoland56
909peripheral bloodno datan/a2016standard therapySweden58
910peripheral bloodHodgkin’s lymphomahematology2016standard therapyGermany32
911peripheral bloodacute myelogenous leukemiahematology2016standard therapyGermany32
912peripheral bloodacute myelogenous leukemiahematology2016standard therapyGermany66
913peripheral bloodT Cell Lymphoma/ NOS - Not otherwise specifiedhematology2016standard therapyGermany55
914peripheral bloodacute myelogenous leukemiahematology2016standard therapyGermany43
915peripheral bloodno datan/a2016standard therapyCzech Republic59
916peripheral bloodaplastic anaemiahematology2016standard therapyUnited Kingdom23
917peripheral bloodmyelodysplastic syndromehematology2016standard therapyGermany73
918peripheral bloodmyelofibrosishematology2016standard therapyIsrael72
919peripheral bloodacute lymphoblastic leukemiahematology2016standard therapyAustralia61
920peripheral bloodprimary myelofibrosishematology2016standard therapyGermany67
921peripheral bloodmyelodysplastic syndromehematology2016standard therapyIreland47
922peripheral bloodno datan/a2016standard therapyGermany17
923peripheral bloodno datan/a2016standard therapyFrance59
924peripheral bloodacute myelogenous leukemiahematology2016standard therapyGermany66
925peripheral bloodchronic lymphocytic leukemiahematology2016standard therapyGermany62
926peripheral bloodacute myelogenous leukemiahematology2016standard therapyFrance47
927peripheral bloodmyelodysplastic syndromehematology2016standard therapyFrance67
928peripheral bloodacute myelogenous leukemiahematology2016standard therapyLithuania15
929peripheral bloodHodgkin’s lymphomahematology2016standard therapyUnited Kingdom18
930peripheral bloodacute myelogenous leukemiahematology2016standard therapyCzech Republic37
931peripheral bloodacute lymphoblastic leukemiahematology2016standard therapyFrance24
932peripheral bloodacute lymphoblastic leukemiahematology2016standard therapyCanada13
933peripheral bloodacute myelogenous leukemiahematology2016standard therapyHungary57
934peripheral bloodacute myelogenous leukemiahematology2016standard therapyBelgium56
935peripheral bloodacute myelogenous leukemiahematology2016standard therapyFrance38
936peripheral bloodacute myelogenous leukemiahematology2016standard therapyFrance52
937peripheral bloodchronic myelomonocytic leukemia, minimal residual diseasehematology2016standard therapyPoland50
938peripheral bloodmyeloma multiplexhematology2016standard therapyGermany63
939peripheral bloodFanconi anaemiahematology2016standard therapyEstonia7
940peripheral bloodplasma cell disorderhematology2016standard therapyFrance47
941peripheral bloodacute myelogenous leukemiahematology2016standard therapyGermany35
942peripheral bloodacute myelogenous leukemiahematology2016standard therapyGermany72
943peripheral bloodmyeloma multiplexhematology2016standard therapyPoland51
944peripheral bloodacute lymphoblastic leukemiahematology2016standard therapySpain58
945peripheral bloodmyelodysplastic syndromehematology2016standard therapyEstonia62
946peripheral bloodacute myelogenous leukemiahematology2016standard therapyHungary46
947peripheral bloodacute lymphoblastic leukemiahematology2016standard therapyHungary20
948peripheral bloodacute myelogenous leukemiahematology2016standard therapyItaly51
949peripheral bloodprimary Immunodeficiencyhematology2016standard therapyRussia5
950peripheral bloodacute myelogenous leukemiahematology2016standard therapyUnited Kingdom62
951peripheral bloodacute myelogenous leukemiahematology2016standard therapyGermany69
952peripheral bloodacute myelogenous leukemiahematology2016standard therapyAustralia51
953peripheral bloodno datan/a2016standard therapyNetherlands58
954peripheral bloodacute myelogenous leukemiahematology2016standard therapySpain38
955peripheral bloodacute lymphoblastic leukemiahematology2016standard therapyLithuania23
956peripheral bloodchronic myeloid leukemiahematology2016standard therapyGermany62
957peripheral bloodHodgkin’s lymphomahematology2016standard therapyGermany32
958peripheral bloodacute lymphoblastic leukemiahematology2016standard therapyGermany27
959peripheral bloodacute lymphoblastic leukemiahematology2016standard therapyPoland30
960peripheral bloodacute myelogenous leukemiahematology2016standard therapyTurkey55
961peripheral bloodacute myelogenous leukemiahematology2016standard therapyIsrael63
962peripheral bloodacute lymphoblastic leukemiahematology2016standard therapyTurkey37
963peripheral bloodacute myelogenous leukemiahematology2016standard therapyGermany66
964peripheral bloodacute lymphoblastic leukemiahematology2016standard therapyTurkey38
965peripheral bloodacute myelogenous leukemiahematology2016standard therapyGermany65
966peripheral bloodacute myelogenous leukemiahematology2016standard therapyPoland46
967peripheral bloodacute myelogenous leukemiahematology2016standard therapyGermany18
968peripheral bloodHodgkin’s lymphomahematology2016standard therapyNetherlands38
969peripheral bloodacute myelogenous leukemiahematology2016standard therapyTurkey48
970peripheral bloodmyelodysplastic syndromehematology2016standard therapyGermany61
971peripheral bloodacute myelogenous leukemiahematology2016standard therapyFrance67
972peripheral bloodno datan/a2016standard therapyPoland55
973peripheral bloodacute myelogenous leukemiahematology2016standard therapyFrance32
974peripheral bloodT-cell acute lymphoblastic leukemiahematology2016standard therapyGermany19
975peripheral bloodmyelodysplastic syndromehematology2016standard therapyUnited Kingdom68
976peripheral bloodacute myelogenous leukemiahematology2016standard therapyGermany59
977peripheral bloodmyelodysplastic syndrome - RCMDhematology2016standard therapyCzech Republic32
978peripheral bloodmyelodysplastic syndromehematology2016standard therapyBelgium65
979peripheral bloodmyelofibrosishematology2016standard therapyNetherlands66
980peripheral bloodacute myelogenous leukemiahematology2016standard therapySwitzerland2/3
981peripheral bloodacute myelogenous leukemiahematology2016standard therapyIsrael36
982peripheral bloodacute myelogenous leukemiahematology2016standard therapyGermany66
983peripheral bloodacute myelogenous leukemiahematology2016standard therapyDenmark68
984peripheral bloodmyelodysplastic syndromehematology2016standard therapySpain15
985peripheral bloodmyelodysplastic syndromehematology2016standard therapyItaly52
986peripheral bloodchronic myelomonocytic leukaemiahematology2016standard therapyFinland53
987peripheral bloodno datan/a2016standard therapyTurkey4
988peripheral bloodleukemiahematology2016standard therapyLithuania53
989peripheral bloodT-cell acute lymphoblastic leukemiahematology2016standard therapySerbia21
990peripheral bloodmyeloproliferative syndromehematology2016standard therapyPoland52
991peripheral bloodacute myelogenous leukemiahematology2016standard therapyFrance63
992peripheral bloodno datan/a2016standard therapyPoland44
993peripheral bloodacute myelogenous leukemiahematology2016standard therapyCzech Republic60
994peripheral bloodT-cell acute lymphoblastic leukemiahematology2016standard therapyAustria41
995peripheral bloodprimary myelofibrosishematology2016standard therapySwitzerland67
996peripheral bloodmyelodysplastic syndromehematology2016standard therapyUnited Kingdom20
997peripheral bloodacute myelogenous leukemiahematology2016standard therapyBrazil37
998peripheral bloodmyelodysplastic syndromehematology2016standard therapyFrance60
999peripheral bloodacute myelogenous leukemiahematology2016standard therapyGermany61
1000peripheral bloodacute myelogenous leukemiahematology2016standard therapyTurkey51
1001peripheral bloodacute lymphoblastic leukemiahematology2016standard therapyFrance28
1002peripheral bloodacute myelogenous leukemiahematology2016standard therapyPoland65
1003peripheral bloodacute myelogenous leukemiahematology2016standard therapyItaly53
1004peripheral bloodLymphoblastic Lymphomahematology2016standard therapyItaly33
1005peripheral bloodacute lymphoblastic leukemiahematology2016standard therapySlovakia30
1006peripheral bloodmyelodysplastic syndromehematology2016standard therapyBelgium9
1007peripheral bloodmyeloma multiplexhematology2016standard therapyPoland38
1008peripheral bloodacute lymphoblastic leukemiahematology2016standard therapyPoland39
1009peripheral bloodmyelodysplastic syndromehematology2016standard therapyAustria61
1010peripheral bloodacute myelogenous leukemiahematology2016standard therapyNew Zealand59
1011peripheral bloodacute myelogenous leukemiahematology2016standard therapyAustralia62
1012peripheral bloodacute myelogenous leukemiahematology2016standard therapyGermany65
1013peripheral bloodacute myelogenous leukemiahematology2016standard therapyPortugal41
1014peripheral bloodmyelodysplastic syndromehematology2016standard therapyFrance59
1015peripheral bloodSAA / Amyloidosishematology2016standard therapyUnited Kingdom45
1016peripheral bloodchronic myeloid leukemiahematology2016standard therapyFinland46
1017peripheral bloodacute myelogenous leukemiahematology2016standard therapyPoland50
1018peripheral bloodacute lymphoblastic leukemiahematology2016standard therapyItaly66
1019peripheral bloodnon-Hodgkin lymphomahematology2016standard therapyRussia38
1020peripheral bloodacute lymphoblastic leukemiahematology2016standard therapyPoland20
1021peripheral bloodmyelofibrosishematology2016standard therapyFrance67
1022peripheral bloodB-cell Acute lymphoblastic leukemiahematology2016standard therapyBelgium44
1023peripheral bloodnon-Hodgkin lymphomahematology2016standard therapyPoland58
1024peripheral bloodacute myelogenous leukemiahematology2016standard therapyGermany72
1025peripheral bloodacute myelogenous leukemiahematology2016standard therapyUnited Kingdom68
1026peripheral bloodmyelodysplastic syndromehematology2016standard therapyGermany63
1027peripheral bloodacute lymphoblastic leukemiahematology2016standard therapyFrance56
1028peripheral bloodacute myelogenous leukemiahematology2016standard therapyPoland54
1029peripheral bloodacute myelogenous leukemiahematology2016standard therapyPoland24
1030peripheral bloodacute lymphoblastic leukemiahematology2016standard therapyGreece9
1031peripheral bloodchronic myeloid leukemiahematology2016standard therapyGermany40
1032peripheral bloodmyelodysplastic syndromehematology2016standard therapyGermany15
1033peripheral bloodmyelodysplastic syndromehematology2016standard therapyGermany37
1034peripheral bloodacute myelogenous leukemiahematology2016standard therapyRussia44
1035peripheral bloodmyelodysplastic syndromehematology2016standard therapyGermany59
1036peripheral bloodnon-Hodgkin lymphomahematology2016standard therapyRussia32
1037peripheral bloodmyelodysplastic syndromehematology2016standard therapyGermany62
1038peripheral bloodacute myelogenous leukemiahematology2016standard therapyPoland55
1039peripheral bloodcomposite lymphomahematology2016standard therapyGermany51
1040peripheral bloodacute myelogenous leukemiahematology2016standard therapyItaly30
1041peripheral bloodacute lymphoblastic leukemiahematology2016standard therapyGermany33
1042peripheral bloodmyelodysplastic syndromehematology2016standard therapyItaly58
1043peripheral bloodhigh-risk acute lymphoblastic leukemiahematology2016standard therapyPoland5
1044peripheral bloodacute myelogenous leukemia M2/M4hematology2016standard therapyGermany59
1045peripheral bloodnon-Hodgkin lymphomahematology2016standard therapyNetherlands39
1046peripheral bloodacute lymphoblastic leukemiahematology2016standard therapyItaly21
1047peripheral bloodacute myelogenous leukemiahematology2016standard therapySpain50
1048peripheral bloodplasma cell disorderhematology2016standard therapyFrance54
1049peripheral bloodacute myelogenous leukemiahematology2016standard therapyUnited Kingdom47
1050peripheral bloodacute myelogenous leukemiahematology2016standard therapyCanada47
1051peripheral bloodmyelodysplastic syndromehematology2016standard therapyGermany67
1052peripheral bloodmyelodysplastic syndromehematology2016standard therapyGermany62
1053peripheral bloodacute myelogenous leukemiahematology2016standard therapyItaly63
1054peripheral bloodacute myelogenous leukemiahematology2016standard therapyPoland19
1055peripheral bloodT-cell-prolymphocytic leukemiahematology2016standard therapyUnited Kingdom61
1056peripheral bloodmyelodysplastic syndromehematology2016standard therapyUSA69
1057peripheral bloodacute lymphoblastic leukemiahematology2016standard therapyFrance35
1058peripheral bloodsevere aplastic anaemiahematology2016standard therapyRussia18
1059peripheral bloodmyelodysplastic syndromehematology2016standard therapyGermany66
Ultima actualizare: 30 Iunie 2017